NR1H4 and Glucose intolerance: To more comprehensively prove our theory, we introduced a FXR agonist into the arsenic exposure scheme to see if a reactivation of the suppressed FXR (by arsenic) could reverse the glucose intolerance, and the results were positive (Figure 3).